MedPath
NMPA Approval

Diprophylline Injection

国药准字H20244540

July 30, 2024

Drug Information

二羟丙茶碱注射液

注射剂

2ml:0.3g

化学药品

July 30, 2024

Company Information

Applicant Company

成都高新区天宇路2号2栋9号

Manufacturing Company

四川省成都市双流区西南航空港经济开发区腾飞二路319号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

二羟丙茶碱注射液 - NMPA 批准文号 | MedPath